Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.47%
1,098.89
-5.21
-0.47%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.87%
609.39
+5.23
+0.87%
—604.16604.16609.44604.12——
SIXE
Energy
SIXE
Energy
SIXE
+0.11%
1,199.15
+1.34
+0.11%
—1,197.811,200.581,213.071,199.31——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.17%
1,737.50
-2.91
-0.17%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.78%
639.37
+4.93
+0.78%
—634.44633.13639.67633.01——
SIXR
Staples
SIXR
Staples
SIXR
-0.37%
837.81
-3.09
-0.37%
—840.90839.53841.73837.19——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.33%
214.43
-0.70
-0.33%
—215.13215.13215.85214.24——
SIXT
Technology
SIXT
Technology
SIXT
-0.69%
3,206.37
-22.34
-0.69%
—3,228.713,225.623,227.743,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.40%
939.66
+3.79
+0.40%
—935.87938.37942.00937.34——
SIXV
Health care
SIXV
Health care
SIXV
+0.21%
1,460.18
+3.06
+0.21%
—1,457.121,452.741,466.881,449.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.78%
2,381.06
-18.78
-0.78%
—2,399.842,389.712,392.302,374.61——
ABCL:NASDAQ
AbCellera Biologics Inc
$4.18
+0.60%
(+0.025) 1D
Apr 27, 10:57:52 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABCL...
Open
$4.15
High
$4.38
Low
$4.13
Mkt. cap
1.28B
Avg. vol.
2.76M
Volume
2.96M
52-wk high
$6.52
52-wk low
$1.94
EPS
-$0.49
Beta
0.85
Shares outstanding
303.16M
No. of employees
562
News stories
From sources across the web
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com
Last report
Feb 24, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.03/ (-0.18 est.)USD
+83.33%beat
Revenue / Estimate
44.85M/ (6.71M est.)USD
+568.85%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
4.24M
17.08M
8.96M
44.85M
Cost of goods sold
42.50M
39.21M
55.03M
50.09M
Cost of revenue
42.50M
39.21M
55.03M
50.09M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.07M
21.99M
24.96M
17.22M
Operating expense
24.40M
27.46M
30.20M
23.34M
Total operating expenses
66.90M
66.67M
85.23M
73.44M
Operating income
-62.66M
-49.58M
-76.28M
-28.58M
Other non operating income
1.62M
5.65M
745.00K
2.16M
EBT including unusual items
-52.98M
-36.34M
-68.77M
-19.50M
EBT excluding unusual items
-52.98M
-36.34M
-68.77M
-20.50M
Income tax expense
-7.36M
-1.62M
-11.65M
-10.55M
Effective tax rate
13.90%
4.45%
16.94%
54.13%
Other operating expenses
-
-
-
-
Net income
-45.62M
-34.73M
-57.12M
-8.94M
Net profit margin
-1,077.24%
-203.27%
-637.84%
-19.94%
Earnings per share
-0.15
-0.12
-0.19
-0.03
Interest and investment income
8.05M
7.59M
6.76M
5.92M
Interest expense
-
-
-
-
Net interest expenses
8.05M
7.59M
6.76M
5.92M
Depreciation and amortization charges
5.33M
5.47M
5.25M
6.12M
EBITDA
-57.33M
-44.11M
-71.03M
-22.46M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer